Date published: 2025-9-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

SYT Activators

SYT activators comprise a class of chemical compounds designed to interact with and modulate the activity of Synaptotagmins (SYTs), a group of integral membrane proteins found primarily in neurons and endocrine cells. Synaptotagmins are crucial components of the synaptic vesicle release machinery, where they play a pivotal role in the process of neurotransmitter release at synapses. These proteins contain multiple C2 domains, specialized regions that bind to calcium ions. Calcium binding to these C2 domains triggers a series of events leading to the fusion of synaptic vesicles with the cell membrane and the subsequent release of neurotransmitters into the synaptic cleft, enabling cell-to-cell communication in the nervous system.

The mechanism of action of SYT activators typically involves their interaction with Synaptotagmin proteins, often targeting specific C2 domains. By binding to Synaptotagmins, these activators can influence the calcium-dependent processes that govern neurotransmitter release. This modulation may lead to alterations in the kinetics or efficiency of vesicle fusion, affecting synaptic transmission. As a result, SYT activators are of significant interest to researchers studying the intricacies of synaptic function, as they offer a means to experimentally dissect and manipulate the processes underlying neurotransmitter release, ultimately advancing our understanding of neuronal communication and signaling. Further investigations into the precise molecular interactions and physiological consequences of SYT activators continue to shed light on the complex machinery orchestrating synaptic transmission.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A is a histone deacetylase inhibitor that can indirectly affect BAF complex activity by altering chromatin structure and gene expression patterns.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

Suberoylanilide Hydroxamic Acid, another histone deacetylase inhibitor, similarly influences chromatin dynamics, potentially impacting BAF complex function.

Panobinostat

404950-80-7sc-208148
10 mg
$196.00
9
(1)

Panobinostat, a broad-spectrum histone deacetylase inhibitor, can indirectly modulate the activity of the BAF complex through changes in chromatin architecture.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$226.00
$846.00
1
(0)

JQ1, a BET inhibitor, potentially impacts the BAF complex indirectly through its effects on chromatin accessibility and gene transcription.

I-BET 151 Hydrochloride

1300031-49-5 (non HCl Salt)sc-391115
10 mg
$450.00
2
(0)

I-BET151, another BET inhibitor, may indirectly influence the BAF complex by altering the transcriptional landscape.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$88.00
$208.00
24
(2)

MS-275, a selective histone deacetylase inhibitor, may have indirect effects on BAF complex activity through epigenetic modulation.

RGFP966

1357389-11-7sc-507300
5 mg
$115.00
(0)

RGFP966, a specific HDAC3 inhibitor, can indirectly impact BAF complex function through histone modification changes.

PFI 3

1819363-80-8sc-507340
10 mg
$300.00
(0)

PFI-3, a SMARCA bromodomain inhibitor, may indirectly influence the BAF complex through its effect on chromatin accessibility.